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Abstract
The Carilion Clinic Breast Diagnostic Center diagnoses approximately 250 women with
breast cancer annually, all of whom are invited to attend the Carilion Clinic Breast
Cancer Support Group (CCBCSG). The primary aim of this project was to evaluate if
participants with more frequent attendance of CCBCSG had increased levels of
preparation for decision-making (PDM) and higher satisfaction with breast cancer
treatment decisions. A REDCap survey was emailed to 137 patients who participated in
at least one CCBCSG within the past five years, with a 39.4% response rate. The survey
assessed levels of patient PDM, patient satisfaction about treatment decisions, and asked
the open-ended question, “What else would you like to share about your CCBCSG
experience and treatment decision making?” Attendance for the CCBCSG was the
independent variable with four levels: one meeting (27.8%), 2-5 meetings (24.1%), 6-10
meetings (20.4%) and 10+ meetings (27.8%). The non-parametric ANOVA test,
Kruskal-Wallis, was used to test for differences in the PDM and patient satisfaction
among the groups of participants, based on the number of support groups they attended.
Descriptive analysis and testing of statistical assumptions were performed with all
quantitative variables. Although the study demonstrated that though the PDMS scores
were not statistically significantly different (p=0.0934) for the four attendance groups,
trends demonstrated that those who attended the most meetings (>10) were more
prepared for decision-making than any other group. Similarly, those who attended 10+
meetings were also statistically more likely to be satisfied with their experience
(p=0.0290).
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Keywords: breast cancer, decision-making, preparation for decision making,
breast cancer support groups, patient satisfaction

vii

PREPARATION FOR DECISION-MAKING AND PATIENT SATISFACTION

1

Breast Cancer Support Groups and Preparation for Decision-Making
Introduction
Rayter (2017) explains that cancer of the breast is an archaic health issue first
illustrated in documents produced by the Egyptians 3000 years before Christ (BC). The
author describes four evolutionary periods that explore the management of breast cancer,
The Empiric period (3000-2500 BC) that documents the first surgical excision of the
breast; the pessimistic period (131-203 AD), which combines surgery with holistic
treatments such as application of milk and vinegar to the tumor to induce shrinkage and
the usage of salicylic acid to eat the tumor away; the optimistic period (1757-1956 AD)
that illuminates the efficacy of surgery and brings about the evolution of the radical
mastectomy; and lastly the realistic period (1960 and ongoing) in which the
understanding of the biology of breast cancer and technological advancements in
imaging, medical oncology, surgical oncology and cancer prevention currently direct
breast cancer treatment recommendations (Rayter, 2017). Rayter (2017) described the
multitudes of treatment recommendations necessary for modern treatment decisionmaking (DM) in breast cancer.
Conversation in the United States among women about a diagnosis of cancer
remained unacceptable until the onset of the twentieth century (Osuch et al., 2012). The
advent of the founding of the American Society for the Control of Cancer (ASCC), which
subsequently evolved into the American Cancer Society (ACS), provided the platform to
begin the conversation about cancer and allowed individuals to reveal their diagnoses
publicly. (Osuch et al., 2012). Rising awareness about cancer diagnoses resulted in the
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development of support groups and catalyzed the formation of political activist groups
(Osuch et al., 2012).
In 1970, Babette Rosamond finally gave voice to the diagnosis of breast cancer
when she published a book about her experience What Women Should Know About the
Breast Cancer Controversy (Osuch et al., 2012). In her publication, Rosamond
challenged women to become involved in the treatment DM process surrounding their
breast cancer diagnosis and not rely only on the advice of the physician; she emphasized
a woman’s right to decide what would be done to her body (Osuch et al., 2012).
Subsequently in 1974, Betty Ford propelled the civic conversation surrounding breast
cancer by publicly speaking about her breast cancer diagnosis in a televised newscast,
forever changing the way media would portray and cover the topic of breast cancer and
advocate for support for those afflicted by the diagnosis (Dubriwny, 2009).
According to Desantis et al. (2016), breast cancer is the second most diagnosed
cancer in women in the United States (US) other than skin cancer and that statistically,
one in eight women will face the diagnosis. The American Cancer Society (ACS) (2017)
reports that in 2017, there were 252,710 new cases of invasive breast cancer diagnosed,
resulting in 40,610 deaths. The death rate declined to 1.3% from 1.9% from 2011-2017
(Augenstein, 2019). The Centers for Disease Control and Prevention (CDC)
acknowledges that the risk for breast cancer is multifactorial, with the two most common
risk factors being female gender and getting older (Centers for Disease Control and
Prevention [CDC], 2019). Because of these risk factors, the average lifetime breast
cancer risk for women is low; about 12% (CDC, 2019). There are greater than ten
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different pathological diagnoses of breast cancer resulting in multiple treatment
algorithms; the most common diagnoses include invasive lobular carcinoma (ILC) and
invasive ductal carcinoma (IDC) (Nounou et al., 2015). It is important to note that the
early detection of breast cancer is directly related to patient prognosis (ACS, 2017).
Women diagnosed with breast cancer face challenging decisions about their
treatment choices and can face anxiety and high emotion at the time of breast cancer
diagnosis (Kokufu, 2012). Unclear evidence and practical tensions among the treatment
options can lead to DM conflict and subsequent negative emotions about their diagnosis
(Lim & Shon, 2016). The investment in making treatment decisions and those who help
shape the treatment decisions hold different significance for each woman, and many
women seek guidance from multiple sources, including family and friends (Wallner et al.,
2017). Many women, however, attend breast cancer support groups during that time to
gather information and receive support, especially those who lack spousal, familial, or
other means of support (Helgeson & Cohen, 2000).
The Carilion Clinic Breast Diagnostic Center (CCBDC), located in Roanoke,
Virginia, is an outpatient diagnostic mammography facility, to which women of all ages
come for diagnostic workups and biopsies for breast problems; breast biopsies result in
the diagnosis of 250 breast cancers annually. The CCBDC also provides the setting and
structure for The Carilion Clinic Breast Cancer Support Group (CCBCSG), established in
2002, which is a bi-monthly, free, facilitated, “rolling” support group; all women
diagnosed with breast cancer at the CCBDC are invited to attend. The CCBCSG process
involves a peer-to-peer discussion about each woman’s unique breast cancer experience,

PREPARATION FOR DECISION-MAKING AND PATIENT SATISFACTION

4

diagnosis, and question exchange concerning emotional and social support and treatment
DM. Women may attend the support group as many or few times as they choose.
The women who attend the CCBCSG, because of their local diagnosis, also share
the care of the same breast cancer specialists. The congruence of breast cancer care
allows for easy dialogue and comparison of treatment modalities, including medications,
surgeries, and ancillary oncology therapies. The women who attend the CCBCSG have
also created a “private” Facebook (FB) page; the CCBCSG invites all women who attend
the group to join the FB page. The purpose of the FB page is to extend the “reach” of the
face-to-face support group.
Background
Breast Cancer Support Groups
According to Gottlieb and Wachala (2007), cancer support groups provide the
structure for a planned intervention for those diagnosed with cancer. Most purport that
support groups involve recurring face-to-face meetings of a small number of survivors
who share the common diagnosis of cancer (Gottlieb & Wachala, 2007). Van Uden-Kran
et al. (2008) stress that people seek out support groups when faced with a serious illness
or traumatic or stressful situations. Breast cancer support groups are highly ranked
compared to other disease-related support groups for sharing information and navigating
a breast cancer diagnosis (Till, 2003). A breast cancer support group provides the
structure for women to seek out tangible emotional, social, and informational support and
to meet others who may be struggling with similar health concerns and treatment choices
(Namkoong et al., 2010; Setoyama, Yamazaki, & Nakayama, 2011). Nationally, breast
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cancer support groups vary in structure such as open versus closed participation, weekly
versus monthly meetings, and educational sessions versus peer support (Cella et al.,
1993; Gottlieb & Wachala, 2007). The groups also happen during various phases of
illness, including the diagnostic phase, the treatment phase, the recovery phase or the
phase of palliative care, as well as vary in length of group sessions (Zabalegui, Sanchez,
Sanchez, & Juando, 2005).
Zabalegui et al. (2005) claim that a support group for those with cancer serves
four basic goals: to permit expression of feelings about living with cancer, to nurture
mutual support of participants in the group, to inform group participants about the illness
and treatment options available, and to improve group members coping skills to resolve
emotional conflict. The structure of support groups provides a beneficial intervention for
patients with cancer resulting in improvements in quality of life, coping and social
relations as well as providing a venue to find understanding, and receive personal
interaction to receive ideas and advice about treatments (Zabalegui et al., 2005;
Winefield, Coventry, Lewis, & Harvey, 2003).
Decision-Making and Breast Cancer Support Groups
Miriam Webster defines decision-making (DM) as “the act or process of deciding
something, especially with a group of people” (2019). Reyna, Nelson, Han, & Pignone
(2015) purport that most unaware people believe that a cancer treatment decision is
straight-forward -- either opt for the treatment that prolongs life or maximizes the life
expectancy from the disease. The authors stress that treatment decisions are much more
difficult and are often complicated by the ambiguity surrounding the effectiveness of
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treatment and the balance of risk versus harm (Reyna et al., 2015). Patient treatment DM
involves reviewing all treatment options, researching the pros and cons of each option,
narrowing treatment choices to pursue, and making the final treatment choice, all of
which must be done to reach a final decision outcome (Reyna et al., 2015).
Weber, Solomon, & Meyer (2013) conclude that a diagnosis of breast cancer
necessitates that women make multiple decisions about their breast cancer treatments.
An enhanced perception of urgency associated with a new diagnosis of breast cancer can
affect the treatment DM process by women diagnosed with breast cancer (Kokufu, 2012;
Brown et al., 2012). Women diagnosed with breast cancer expect emotional and
substantial support in the process of treatment DM (Lim & Shon, 2016).
Patients who are directly involved in the process of treatment DM make more
significant and effective progress on all decision-related outcomes (Brown et al., 2012).
There is evidence about online support groups and the effects of DM and insight into how
support groups may assist in the process of preparation for decision-making (PDM).
Silence (2013) examines the way that cohorts exchange information in an online breast
cancer support group for use in DM. Study results detail that most women ask for advice
by disclosing information about their diagnosis or asking for opinions; women structure
questions to target similar people, and most advice-solicited is for social or emotional
support (Silence, 2013). Similarly, Wallner et al. (2016) and Bruce ,Tucolka, Steffens, &
Neuman (2015), examine the use of online breast cancer support for DM. The authors
explore how much women with breast cancer utilize online resources for treatment DM,
and if it helped their decisions (Wallner et al., 2016). Study results found that frequent
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users of online information had more positive experiences with treatment decisions than
infrequent users (Wallner et al., 2016). Bruce et al. (2015) evaluate the quality of online
information to support treatment DM for breast cancer. The study concludes that many
websites exist for women diagnosed with breast cancer to seek information about DM;
however, most do an inadequate job of providing reliable and prerequisite details
necessary for adequate treatment DM. Although there is less evidence about treatment
DM for women experiencing breast cancer who elect to attend in-person support groups,
strong evidence in this area for online support groups that DM is a worthwhile outcome
to measure. Moreover, the known complexity of the decision at hand further supports
this measure.
Patient Satisfaction and Breast Cancer Support Groups
Jefford and Tattersail (2002) relay that patient acquisition of health information
about a cancer diagnosis and treatment options are beneficial, and results in an increase in
patient satisfaction and clinical outcomes. Women diagnosed with breast cancer often
attend support groups to glean treatment information, but the question remains whether
the attendance of a support group is a satisfying experience? Review of the literature
reveals two studies that measure patient satisfaction from the attendance of a breast
cancer support group, suggesting that patient satisfaction is an important outcome
measure for such groups.
Glachen and Magen (1995) conducted a pilot study that evaluated the process,
outcomes, and satisfaction in three different types of community-based breast cancer
support groups that meet over an eight-week period. The authors noted that a group
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facilitator was present at the meetings and that members of the group provided the agenda
for each meeting (Glachen & Magen, 1995). Meeting attendees, after conclusion of the
group process, received a post group satisfaction questionnaire that inquired about group
process and consumer satisfaction about the group. The questionnaire contained three
consumer satisfaction questions, and two open-ended questions inquiring what each
patient liked or disliked about the group (Glachen & Magen, 1995). Survey outcomes
revealed that on a Likert scale of 1-5, one being dissatisfied and five being very much
satisfied, their experience rated 4.61, inferring that clients are very satisfied with the
support group experience (Glachen & Magen, 1995).
Morse, Gralla, Petersen, & Rosen (2014), explored patients and care-givers
partialities in the support group process and content to be discussed at a support group to
evaluate the members’ satisfaction with the group experience. The cross-sectional design
of the study included demographic and clinical variables, including perception of social
support, and compared information between patients and the caregivers who attended the
group (Morse et al., 2014). Variables included demographic and background data, topic
importance ratings, and social support; group satisfaction was compared between patient
and caregiver using chi-square (Morse et al., 2014). Nine hundred thirty-four participants
reported group satisfaction data, resulting in group satisfaction ratings of 43% and 33%
from patients and caregivers, respectively; fewer than half of those participating in the
group reported satisfaction with the experience (Morse et al., 2014).
Preparation for Decision-Making Scale Used in a Breast Cancer Support Group
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Hawley, Newman, Griggs, Kosir, & Katz (2016) explored the use of a decision
aid/intervention for improving DM in patients with breast cancer. The authors relayed
that provision of an interactive decision tool or platform assisted patients with difficult
treatment decisions (2016). Bennett et al. (2010) communicated that the use of patient
decision aids is helpful in treatment DM because they provide options, clarify values, and
add to recommendations made by the health care provider. This study evaluated the
validity of the preparation for DM scale, which was used to evaluate levels of preparation
for DM gained from the use of decision aids/interventions; only 68 studies reference the
preparation for DM validation study (Bennett et al., 2010).
Stacey et al. (2012) explored cancer treatment-decision making and examined the
extent that cancer patients perceived they were involved in the DM process, and what
specific factors influenced their decisions. Stacey et al. (2012) used the PDMS as one of
their instruments in this descriptive study. Results reveal that patients were more
involved in the DM process when offered decision choices, but the study did not involve
or use a breast cancer support group as the decision aid/intervention to improve
preparation for DM (Stacey et al., 2012). Literature review reveals no evident studies
that evaluate or measure levels of preparation of DM resulting from attendance of a
breast cancer support group.
Theoretical Framework
In 1965, a group of community leaders from healthcare and business-related
organizations convened to discuss factors that affected public health, such as social and
economic research, the structure of community health organizations, and health care
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quality (Ayanian & Markel, 2016). Among this group of leaders was Avedis
Donabedian, who at the time was a medical school professor contracted to evaluate
research specific to the assessment of healthcare quality (Ayanian & Markel, 2016).
Donabedian’s research led to the publication of “Evaluating the Quality of Medical Care”
in 1966, which outlined the make-up for his theoretical framework of health care quality
(Donabedian, 2005).
Donabedian’s theoretical framework is composed of the three components of
structure, process, and outcomes, which assess health care quality (Donabedian, 2005).
Donabedian defined “structure” as the health care setting, provider qualifications,
staffing, and health care equipment; “process” as the elements and appropriateness of
care delivery and evaluation of medical error; and “outcomes” as progression of illness,
survival, and complications in care or illness (Donabedian, 2005).
Donabedian’s framework provides the optimum platform for this scholarly
project. The CCBCSG provides the support group (structure) with interactive discussion
(process) in place. The assessment of increased levels of preparation for DM through
participation in the CCBCSG and levels of patient satisfaction will provide the outcomes
for the study (see Figure 1).
Problem/Purpose/Aims
Women who attend the CCBCSG state anecdotally, that the face-to-face support
group process is fulfilling and provides a platform that assists in making satisfying
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treatment decisions and building lasting friendships and support. The women also report
regret when they must miss a meeting.
Despite anecdotal local evidence, and evidence in the literature to support positive
outcomes for breast cancer support groups, it is problematic that there is no assessment of
the outcomes for patient’s PDM and higher patient satisfaction for the local CCBCSG.
Thus, the purpose of this project was to complete an evidence-based assessment of these
outcomes for the local CCBCSG.
The primary aim of this project was to evaluate if participants with more frequent
attendance of CCBCSG have increased levels of PDM and higher satisfaction with breast
cancer treatment decisions. The secondary aim was to identify other potential outcomes
of group attendance.
Methods
Survey Implementation
This evidence-based study was a cross-sectional survey that included the PDMS
instrument and single item demographic question created by the research team. The
study was mixed method in design. Approximately 137 participants who have attended
the CCBCSG from 2014-2019 were recruited via an emailed survey that they were asked
to complete and return. A reminder email was sent to the participants who had not
responded to the survey, 2 weeks after the first survey had been sent as suggested by
Dillman, Tortora, & Bowker, 1998). Survey design followed the recommendations of
Dillman et al. (1998) to keep coverage error, sampling error, measurement error, and
non-response error low. Survey design began with a motivational welcome screen that
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provided simple instruction on actions needed to continue to the next page to begin the
survey (Dillman et al., 1998). Each question in the survey was constructed in a similar
format. Survey questions were easy to comprehend and limited in length (Dillman et al.,
1998). The format of the survey allowed the respondent the ease of scrolling from
question to question to complete it (Dillman et al., 1998). Carilion Clinic's REDCap
(Research Electronic Data Capture) (Harris et al., 2019) software was used as the central
location for data collection. Key facilitators for this study included support from the
REDCap (Harris et al., 2019) team in survey design, data collection, and data analysis.
REDCap (Harris et al., 2019) provided a secure, web-based application designed to
support data management and collection for research/QA/QI studies. Carilion's REDCap
(Harris et al., 2019) servers are securely housed on-site in a limited access data center,
and all data are stored on Carilion's firewall-protected network. The Health Analytics
Research Team (HART) supported the proper development of the project and survey in
REDCap (Harris et al., 2019), observing appropriate change control and enforcing
appropriate security controls. Data collection projects were built with a study-specific
data dictionary, enforcing intuitive, accurate, consistent, and complete data entry.
REDCap (Harris et al., 2019) also provided a survey tool for building and managing
online surveys. The time frame to review returned surveys was one month from the first
recruitment email. The HART team analyzed all collected data using SAS Enterprise
Guide version 7.11 (SAS Institute, 2015).
Demographics
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The REDCap (Harris et al., 2019) survey contained demographic questions, as
well as the survey instrument. For the demographic section, patients were asked to
identify their race, age, preferred language, access to the internet and type of breast
cancer diagnosis.
Preparation for Decision-Making Scale
The REDCap (Harris et al., 2019) survey also contained the instrument for the
study, which was the well-validated (Bennet et al., 2010) PDMS instrument from the
Ottawa Hospital Research Institute (The Ottawa Hospital Research Institute [OHRI],
2019). The PDMS instrument can be found in Appendix A. The internal consistency in
the validation article ranged from α=0.92 to α=0.96, which is very strong (Bennett et al.,
2010). Additionally, the authors relayed that this scale/instrument, specific to practice
implications, is well designed to evaluate the complex healthcare decisions patients must
make.
Satisfaction with Treatment Decisions
The REDCap (Harris et al., 2019) survey contained one Likert-type, five-level
patient satisfaction question. The patients were asked to choose a level of satisfaction
(very satisfied – 1 to very unsatisfied – 5) with treatment decisions. The question and
response choices can be found in Appendix B.
Qualitative Assessment
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The REDCap (Harris et al., 2019) survey included the open-ended question,
“What else would you like to share about your CCBCSG experience and treatment
decision-making?”. This question was used to investigate the secondary aim of this
study, to identify other potential outcomes of group attendance.
Ethical Considerations
Institutional Review Board (IRB) approval was obtained from the Carilion Clinic
Healthcare System and James Madison University to perform this study. Patients
performed a waiver of written verification of consent by completing the survey. There
were no ethical concerns for patients participating in this study. There was no direct
benefit to individuals who participated in this study, outside of knowing that their
feedback may contribute to science at large. There was a potential benefit to the local
healthcare system since findings may guide the system in its evaluation of the CCBCSG
and potentially build understanding of outcome measures for other similar support group
programs. These findings may also be helpful to oncology nurses as they work with
administration to develop these programs. These findings may also be used to begin
testing outcomes for other local support groups. Moreover, publications of this work
may inform the science on this topic such that future scientists know whether to research
PDM and satisfaction as outcomes for breast cancer support groups and hence benefit
nursing and medical science. One potential conflict of interest is that the study primary
investigator works within this system and has work responsibilities for the support group.
This risk was mitigated by including other expert researchers and clinical experts in all
aspects of the study design, implementation, and analysis.
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Analysis
Descriptive analysis was completed for all quantitative variables. Counts,
percentages, standard deviations, and means were calculated as appropriate for each
variable. Attendance frequency was calculated by the patients’ responses to the survey
question pertaining to the number of times they participated in the group sessions.
PDMS
The PDMS instrument consisted of ten Likert-type questions with the higher
score indicating a higher level of PDM. The PDMS score was calculated by totaling all
10 items in the instrument and dividing the sum by ten following methods recommended
by Bennet and colleagues (2010).
Patient Satisfaction
The patient satisfaction rating was determined from the Likert-type response to
one specific satisfaction question, “Overall, how satisfied are you with your experience of
attending the CCBCSG to help you make breast cancer treatment decisions?” Mean
patient satisfaction scores were calculated by averaging the patient satisfaction scores for
each patient included in each attendance group. A lower patient satisfaction score
indicates a patient with a higher level of satisfaction (i.e., 1-very satisfied, 5-very
unsatisfied).
Testing of Differences
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The, Kruskal-Wallis test, was used to test for differences among the groups of
participants, based on the number of support groups they attended, to determine whether
there were differences in PDM and patient satisfaction (Aim 1).
Narrative Analysis
An open-ended question, “What else would you like to share about your
CCBCSG experience and treatment decision making?” was used to collect qualitative
data on participants to identify any additional potential outcomes of support group
attendance (AIM 2). Qualitative content analysis followed Graneheim and Lundman’s
2004 procedures to describe responses to the open-ended question (Aim 2) (Graneheim &
Lundman, 2004). For this, all participant comments were broken down into the simplest
meaningful unit, coded, grouped into categories, and used to identify themes (Graneheim
& Lundman, 2004). Quantitative data were entered into SAS Enterprise Guide version
7.11 (SAS Institute, 2015) for analysis. Qualitative research data relied on Sandelowski’s
(2001) assertion that numbers are valuable in presenting qualitative work to establish its
worth, document what is identified about the research topic, describe the study sample,
and generate meaningful data.
Results
Out of the 137 surveys sent to participants of the CCBCSG, 55 surveys were
answered. One survey was not completed; therefore, 54 patients completed the survey
and were used in the analysis for a 39.4% response rate. Attendance for the CCBCSG,
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the independent variable, was categorized into four groups: one meeting (27.8%), 2-5
meetings (24.1%), 6-10 meetings (20.4%) and 10+ meetings (27.8%).
Demographic Information
Most patients who completed the survey were English speaking (90.7%) and
Caucasian (98.1%). 55.6 % of the patients who completed the survey fell into the age
range of 30-49 years. Additional demographics can be found in Table 1. Two breast
cancer types, Ductal Carcinoma in Situ (DCIS) and Invasive Ductal Carcinoma (IDC),
accounted for 74.1 % of all patients’ self-reported breast cancers. Additional breast
cancer information is provided in Table 2.
PDMS Score
The PDMS scores were not statistically significantly different (p=0.093) based on
the attendance groups. Out of the potential ranges of meeting attendance of 10+, 6-10, 25, and 1, those patients who attended 10+ meetings had the highest PDMS score
(M=4.35, SD=0.78) and those who attended only one meeting had the lowest PDMS
score (M=3.33, SD=1.34) (see Figure 2). For the patients who attended 2-5 meetings and
6-10 meetings, their PDMS average scores were 4.08 (SD=0.77) and 3.53 (SD=1.63),
respectively.
Patient Satisfaction Score
Patients who attended 10+ meetings were the most satisfied (mean=1, SD=0) with
all 15 patients selecting “very satisfied” as their response to the patient satisfaction
question. Those who attended only one meeting were the least satisfied (mean=1.87,
SD=1.30). For the patients who attended 2-5 meetings and 6-10 meetings, their average
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satisfaction scores were 1.15 (SD=0.38) and 1.45 (SD=0.69), respectively (See figure 3).
The overall patient satisfaction score was statistically significantly different (p=0.0290)
among the four different attendance group levels. A posthoc analysis (Dwass, Steel,
Critchlow-Fligner Method) was used to determine which levels were statistically
different from one another. The analysis indicated that people who attended 10+
meetings were statistically more satisfied (p=0.038) with their overall experience than
those who attended only one meeting.
Qualitative Assessment
The open-ended question (“What else would you like to share about your
CCBCSG experience and treatment decision-making?”) used for the qualitative analysis
was completed by 38 (70.4%) of the 54 participants. 34 of the 38 participants (89.5%)
claimed to gain some form of support from attending the support group sessions (see
figure 4). Keywords used in patient responses were “supportive”, “sisterhood”,
“empowering”, “reassuring”, “valuable”, “companionship”, etc. Four out of the 38
patient responses (10.5%) to the qualitative question did not claim to receive any support
from attending group sessions, because of finding their diagnosis harder to discuss with
strangers and experiencing increased stress after listening to others’ testimonials.
Discussion
This study intended to investigate if patients who had a more frequent attendance
of CCBCSG had higher levels of PDM and satisfaction with treatment decisions. Hawley
et al. (2016) explored the use of a decision aid for improving patient treatment DM, but to
the best of our knowledge, this study is the first to use the PDMS instrument as a decision

PREPARATION FOR DECISION-MAKING AND PATIENT SATISFACTION

19

aid to measure levels of preparation for PDM in a breast cancer support group. The
results of this study indicate that while attendance frequency may be important to patient
outcomes other factors are also likely important and that more information is needed not
only about the frequency of attendance but also about support group characteristics such
as meeting mode (in-person vs. online) and group dynamics.
Weber et al. (2013) supported that a breast cancer diagnosis requires that women
must make multiple decisions about their treatment. Brown et al. (2012) also claimed
that patients who are directly involved in their process of treatment DM make more
meaningful and effective progress on all decision-related outcomes. The study
demonstrated that even though the PDMS scores were not statistically significantly
different (p=0.093) for the four attendance groups, the analysis supported that patients
who attended the CCBCSG most often (10+) had a higher level of PDM than any other
group. Additionally, one-half of the patient qualitative survey responses specifically
mentioned decision-making as a benefit of group attendance such as, “It’s extremely
helpful to bounce ideas off other women who are facing the same decisions,” “There is
support for any and all decisions to be made even when women make different choices.
Someone else has always been there first. No judgment, ever. Unconditional,” and “The
group helps me make choices about my treatment and the results I want to experience.”
Together these findings indicate that some participants find support groups help
them to prepare for DM specifically and that either those who attend most often are likely
to feel prepared to make decisions or conversely those who feel prepared to make
decisions subsequently elect to attend more frequently. This indicates that PDM is an
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important outcome measure for breast cancer support groups and that more research is
needed to better understand the relationship between attendance, attendance frequency,
and PDM.
Conversely, some participants do not find support groups to be helpful. One
outlier comment was that the group was “the worst experience of my breast cancer
journey”. However, others too found this group to be less supportive.
Based on the quantitative results the question remains whether persons who were
most satisfied attended the group more often; a logical conclusion. However, the
qualitative comments enrich the understanding of this support. Approximately one-half
of the survey responses also mentioned patient satisfaction as a direct benefit of group
attendance such as “This group helped with the feeling of being overwhelmed,” and “The
CCBCSG offered me a lifeline during my cancer treatment, and I hung on tight! I
continue to feel empowered by the information and support the group provides.”
The qualitative analysis of the study corroborates Zabalegui et al.’s (2005) claim
that a cancer support group serves four basic goals: permits expression of feelings,
nurtures mutual support, informs participants about treatment options, and improves
coping skills. Lim and Shon (2016) also reported that women with a new breast cancer
diagnosis expect emotional and substantial support with treatment DM. Examples from
the CCBCSG survey respondents’ statements supporting these findings and included
“The group changed my entire perspective on my cancer, my treatment, and the
importance of having a safe place to talk with other survivors,” and “I am inspired by all
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the women in the group and do not feel alone in my diagnosis and decisions I have facing
me.”
Interestingly, participants continued to participate in the support group process
because they wanted to help support those women who were newly diagnosed with breast
cancer and help them begin making treatment decisions and provide emotional support.
Two direct participant responses supporting this finding stated “The support group has
been such a help to me and I appreciate the feeling that it provides the opportunity to be
helpful to other members,” and “Most of my decisions were already made before I joined
the group – I’m several years out, so I benefit from attending in other ways that are
supportive to me and others.”
Zabalegui et al. also (2005) noted that women attend support groups during
various phases of illness. This study, however, did not collect data that would correspond
to each specific phase of illness the support group attendees were experiencing as they
attended group meetings. Further research could explore what treatment phases were the
most common for group attendance.
Limitations
The study sample was limited in size and diversity and, therefore, not likely to be
representative of the full population of patients who have attended the CCBCSG over
time. The findings also may not be generalizable to all patients who have attended the
CCBCSG. The data for the study collected may have been influenced by recall bias as to
how many meetings may have been attended. Some patients may have already made a
treatment decision before attending the CCBCSG, therefore reducing the impact group
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attendance would have on their PDM. Older patients or those with less technical savvy
may have had a harder time understanding and completing an online survey. There were
no significant barriers to the study due to administrative and HART team support.
Constructive consequences of the project included that respondent groups, as a
consequence of self-selection of survey answers, were evenly distributed and that all 15
group members who attended 10+ meetings noted that they were very satisfied with the
group. The negative open-ended comment that touted the group as “the worst experience
of my breast cancer journey” was an unintended negative consequence of the study.
Implications
The current study increases the knowledge of nurses and other breast cancer care
providers about how attendance of a breast cancer support group can assist patients in
making important and satisfying treatment decisions. The study highlights the role that
oncology nurses can hold as advocates for their breast cancer patient population. It also
allows the realization of the value that breast cancer support groups afford their patients
to share comparable experiences and exchange information with others in similar
circumstances. Oncology nurses are in a strategic position to implement and develop
cancer support groups within their institutions and garner administrative support in order
to sustain them. The evaluation of treatment DM in a breast cancer support group in this
study may be used as an exemplar for other institutions when evaluating the best
survivorship care for their cancer patient populations.
Conclusion
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Many patients diagnosed with breast cancer need to obtain satisfying information
about treatment DM and receive support throughout their cancer journey. This study
demonstrates that women who have more frequent attendance of a breast cancer support
group can gain satisfying support in making treatment decisions through support group
attendance. Further research could include investigating if support group attendance is
more beneficial to patients in different phases of their illness, as well as investigating the
benefits women who continue coming to a support group get out of supporting others
with a new diagnosis.
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Appendix A – Patient Preparation for Decision Making Scale
Preparation for Decision Making Scale
Definition - The Preparation for Decision Making scale assess a patient’s perception of
how useful a decision aid or other decision support intervention is in preparing the
respondent to communicate with their practitioner at a consultation visit and making a
health decision (treatment/diagnostic/screening, etc.)
Preparation for Decision Making Scale
Please show your opinion of the Carilion Clinic Breast Cancer Support Group
(CCBCSG) by circling the number to show how much you agree with each statement.
Not at all

A little

Somewhat

Quite a
bit

A great deal

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Did the
CCBCSG….
1.

2.

3.

4.

5.

6.

7.

8.

Help you
recognize that a
decision needs to
be made?
Prepare you to
make a better
decision?
Help you think
about pros and
cons of each
option?
Help you think
about which pros
and cons are
most important?
Help you know
that the decision
depends on what
matters most to
you
Help you
organize your
own thoughts
about the
decision?
Help you think
about how
involved you
want to be in this
decision?
Help you
identify
questions you
want to ask your
doctor?
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9.

Prepare you to
talk to your
doctor about
what matters
most to you?
10. Prepare you for a
follow-up visit
with your
doctor?

1

2

3

4

5

1

2

3

4

5

Preparation for Decision Making Scale © JD Graham, AM. O’Conner 1995, revised 2005
Directions for Use
This questionnaire is administered after a patient visits their practitioner to discuss
treatment options, etc.
Scoring and Interpretation
a) Items can be summed and scored (sum the 10 items and divide by 10).
b) Scores can be converted to a 0-100 scale by: subtracting 1 from the summed score
in part a) and multiplying by 25.
High scores indicate higher perceived level of preparation for decision making.
Psychometric Properties
Alpha coefficient ranges from .92 to .96 [1,2,4] Item-total correlation analyses were also
high (0.75-0.81).[4]
Scale discriminates significantly between different decision support interventions [1,4];
the effect size is 1.8 [1]
Total test reliability is high at 0.944. [4]
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Appendix B – Single Item Patient Satisfaction Question
“Overall, how satisfied are you with your experience of attending the Carilion Clinic
Breast Cancer Support Group to help you make breast cancer treatment decisions? “
Circle one response.
Very Satisfied

Satisfied

Neutral

Unsatisfied

Very Unsatisfied
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Appendix C – Table 1 – Patient Demographics
Table 1
Demographics
Variables
Race
Caucasian
African American
English Speaking
Yes
No
Age Range
30-49
50-69
70+
Access to Internet
Yes
Blank

N (%)
53 (98.1%)
1 (2.0%)
49 (90.7%)
5 (9.3%)
11 (20.4%)
30 (55.6%)
13 (21.4%)
53 (98.1%)
1 (1.9%)
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Appendix D – Table 2 – Breast Cancer Type
Table 2
Breast Cancer Type
Types
Ductal Carcinoma in Situ (DCIS)
Lobular Carcinoma in Situ (LCIS)
Invasive Ductal Carcinoma (IDC)
Invasive Lobular Carcinoma (ILC)
Inflammatory
Other (ACC and Triple Negative)
Blank

N (%)
11 (20.4%)
1 (1.9%)
29 (53.7%)
8 (14.8%)
1 (1.9%)
2 (3.7%)
2 (3.7%)
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Appendix E – Figure 1 – Donabedian Model
Figure 1. Donabedian Model
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Appendix F– Figure 2 – Preparation for Decision Making Average Scores Per
Attendance Groups
Figure 2. Preparation for Decision Making Average Scores Per Attendance Groups

Figure 1. The PDMS Score was not statistically significantly different (p=0.093) between
the four attendance groups.
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Appendix G – Figure 3 – Overall Patient Satisfaction Ratings
Figure 3. Overall Patient Satisfaction Ratings

3 - Neutral
5%
2 - Satisfied
13%

4 - Unsatisfied
2%

5 - Very
Unsatisfied
2%

1 - Very Satisfied
2 - Satisfied
3 - Neutral
4 - Unsatisfied

1 - Very Satisfied
78%
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Appendix H – Figure 4 – Aim 2 Results – Qualitative Assessment
Figure 4. Aim 2 Results - Qualitative Assessment

40

